AG
LJPC

Artal Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Artal Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-200,000
Closed -$4.03M – 123
2018
Q3 		$4.03M Sell
200,000
-50,000
-20% -$1.31M 0.1% 82
2018
Q2 		$7.29M Sell
250,000
-50,000
-17% -$1.54M 0.16% 57
2018
Q1 		$8.93M Buy
+300,000
New +$9.67M 0.11% 51

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group's LJPC Position: Q4 2018 in Review

Artal Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2018, closing a stake of 200,000 shares — an estimated $4.03M sold.

Artal Group first reported a position in LJPC in Q1 2018 and held it in 3 quarters. The position peaked at $8.93M in Q1 2018. 83 funds tracked by Wall St. Rank hold LJPC as of Q4 2018.

  • Artal Group reported no remaining La Jolla Pharmaceutical Company position as of Q4 2018 after selling out during the quarter.
  • Artal Group sold 200,000 La Jolla Pharmaceutical Company shares in Q4 2018, an estimated $4.03M.
  • Artal Group first reported a position in La Jolla Pharmaceutical Company in Q1 2018 and held it in 3 quarters.
  • Artal Group's La Jolla Pharmaceutical Company position peaked at $8.93M in Q1 2018.
  • 83 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2018.

Based on Artal Group's 13F filing for Q4 2018, filed 11 Feb 2019.